Stone X Group Inc. Cardiol Therapeutics Inc. Transaction History
Stone X Group Inc.
- $2.06 Trillion
- Q2 2025
Shares
1 transactions
Others Institutions Holding CRDL
# of Institutions
44Shares Held
6.71MCall Options Held
37.6KPut Options Held
0-
Tejara Capital LTD London, X03.27MShares$4.05 Million2.06% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD857KShares$1.06 Million0.22% of portfolio
-
Lion Street Advisors, LLC340KShares$421,6310.15% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9293KShares$363,3890.15% of portfolio
-
Pvg Asset Management Corp Golden, CO283KShares$351,5051.46% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $76.8M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...